The 3477 drug test is a laboratory order code, most commonly associated with Quest Diagnostics, for a comprehensive urine drug screen that checks for a broad range of commonly misused substances. Unlike a standard five-panel workplace test that covers only the federally mandated drug classes, the 3477 panel typically screens for ten or more categories of drugs in a single specimen. Because the code is lab-specific rather than standardized by a regulatory body, the exact lineup can vary slightly depending on the ordering physician’s preferences, but the core panel and the technology behind it are well established.
Which Drugs the Panel Covers
A comprehensive urine drug screen like the 3477 panel generally targets the drug classes most likely to show up in clinical and occupational settings. While a basic five-panel test covers amphetamines, cannabinoids (THC), cocaine, opiates, and phencyclidine (PCP), the broader panel adds several more categories. A typical 3477-style comprehensive screen includes:
- Amphetamines: methamphetamine, MDMA, and related stimulants
- Barbiturates: phenobarbital, butalbital, and similar sedatives
- Benzodiazepines: diazepam, alprazolam, clonazepam, and others
- Cannabinoids: THC and its metabolites
- Cocaine: detected through its metabolite benzoylecgonine
- Methadone: screened separately from other opioids
- Opiates: morphine, codeine, and heroin (via 6-acetylmorphine)
- Oxycodone: often screened on its own because standard opiate assays miss it
- Phencyclidine (PCP): the dissociative anesthetic
- Propoxyphene: historically included, though the drug was withdrawn from the U.S. market; some panels have replaced this slot with buprenorphine or another substance
Some versions of the panel also include a tricyclic antidepressant screen or an expanded opioid category that picks up fentanyl or tramadol. The exact lineup depends on what the ordering provider requests. If you are told you need a “3477” test and want to know precisely what is on your panel, the requisition form or the lab’s online test menu will list each analyte by name.
How the Screening Step Works
The first pass on your urine sample uses immunoassay technology. Each drug class has its own reagent designed to react with the target substance or its metabolites. When the concentration in your urine crosses a pre-set threshold, the assay flags the result as “presumptive positive.” Laboratories commonly run these assays on automated chemistry analyzers that can process a full panel on one specimen in minutes.1Clinical Chemistry. Discovering Cross-Reactivity in Urine Drug Screening Immunoassays through Large-Scale Analysis of Electronic Health Records The word “presumptive” is important: an immunoassay screening result is not a final answer. It tells the lab that something in your sample reacted with that particular assay above the cutoff. That “something” could be the target drug, or it could be a structurally similar compound that the antibody cannot distinguish.
Cutoff Concentrations and Why They Matter
Every immunoassay has a cutoff level, measured in nanograms per milliliter (ng/mL), below which the result is reported as negative even if trace amounts of a drug are present. These thresholds exist to balance sensitivity against the risk of false alarms. The cannabinoid cutoff for most workplace and clinical screens sits at 50 ng/mL. The opiate cutoff has its own history: U.S. workplace testing programs raised the screening cutoff for codeine and morphine from 300 ng/mL to 2,000 ng/mL in late 1998, because the lower threshold was catching people who had eaten poppy-seed foods or taken small therapeutic doses of codeine.2Journal of Analytical Toxicology. Experience with a Urine Opiate Screening and Confirmation Cutoff of 2000 ng/mL
Amphetamines typically carry a 1,000 ng/mL cutoff, cocaine metabolite 300 ng/mL, and PCP 25 ng/mL. Benzodiazepines and barbiturates vary by lab but usually fall around 200 and 300 ng/mL respectively. The key point for anyone facing a drug test is that a “negative” result does not mean zero drug was present; it means the concentration fell below the cutoff. And a “positive” screen does not prove illicit use; it triggers the next step.
What Happens After a Presumptive Positive
A presumptive positive on the immunoassay screen leads to confirmatory testing, which uses a completely different technology. The gold standard has long been gas chromatography–mass spectrometry (GC-MS), but many labs have shifted to liquid chromatography–tandem mass spectrometry (LC-MS/MS) because it can identify a wider range of compounds with less sample preparation.3Journal of Analytical Toxicology. Comparison of LC–MS-MS and GC–MS Analysis of Benzodiazepine Compounds Included in the Drug Demand Reduction Urinalysis Program Professional guidelines recommend that confirmation always pair a chromatographic separation step with mass spectrometry, because that combination can pinpoint the exact molecule rather than relying on an antibody reaction.4PubMed Central. Performance Evaluation of three Liquid Chromatography Mass Spectrometry Methods for Broad Spectrum Drug Screening
Confirmatory testing has its own set of cutoffs, often lower than the screening cutoffs. For example, while the screening cutoff for THC metabolite is 50 ng/mL, the confirmation cutoff is usually 15 ng/mL. The confirmation step also tells you exactly which substance triggered the screen. If an opiate immunoassay flags positive, confirmation can distinguish between morphine, codeine, hydrocodone, and heroin-specific metabolites. Only results that survive both screening and confirmation are reported as positive.
Specimen Validity Testing
Along with running the drug assays, the lab checks whether your urine sample is actually real, undiluted human urine. Specimen validity testing measures creatinine concentration, specific gravity, and pH.5Journal of Analytical Toxicology. Catching Fakes: New Markers of Urine Sample Validity and Invalidity The sample’s temperature at the time of collection is also checked, because a specimen brought in from outside the body will usually be too cool.
A specimen is flagged as “dilute” when the creatinine is between 2 and 20 mg/dL and the specific gravity falls between 1.0010 and 1.0030. That can happen naturally if you drank a large amount of water before the test, but it also raises suspicion. A “substituted” specimen has creatinine below 2 mg/dL or specific gravity outside the range consistent with human urine altogether, suggesting someone swapped the sample. A pH below 3 or above 11 marks the specimen as “adulterated,” meaning a foreign substance was added to try to destroy the drug metabolites.6PubMed Central. Urine specimen validity test for drug abuse testing in workplace and court settings Substituted and adulterated results are treated as seriously as a positive drug test in most workplace programs. A dilute result usually means you will be asked to retest.7Journal of Analytical Toxicology. The Characterization of Human Urine for Specimen Validity Determination in Workplace Drug Testing: A Review
False Positives and Cross-Reactive Medications
One of the biggest anxieties around a comprehensive drug screen is the possibility of a false positive from something you legitimately take. That anxiety is not unfounded. Immunoassay screens can cross-react with a surprisingly long list of medications, including some available over the counter. Documented false-positive triggers span multiple drug classes: antihistamines like brompheniramine, antidepressants like bupropion, sertraline, trazodone, and venlafaxine, antipsychotics like quetiapine and chlorpromazine, the pain relievers ibuprofen and naproxen, the acid-reducer ranitidine, and even the calcium channel blocker verapamil.8PubMed. Commonly prescribed medications and potential false-positive urine drug screens
The amphetamine assay is particularly notorious for cross-reactivity. Nasal decongestants containing pseudoephedrine or phenylpropanolamine, the ADHD medication atomoxetine, and even over-the-counter Vicks inhalers (which contain levomethamphetamine) have all triggered false positives on amphetamine screens.9PubMed Central. Amphetamine Positive Urine Toxicology Screen Secondary to Atomoxetine False positives have also been described for opiate, benzodiazepine, cannabinoid, tricyclic antidepressant, PCP, LSD, and barbiturate assays.10Journal of Analytical Toxicology. False-Positive Interferences of Common Urine Drug Screen Immunoassays: A Review
The critical thing to understand is that a false positive on the immunoassay screen should be caught by the confirmatory step. GC-MS or LC-MS/MS can tell the difference between methamphetamine and levomethamphetamine, or between a benzodiazepine and a cross-reacting antihistamine. If your screen comes back positive and you know you take a medication that might cross-react, make sure the lab runs confirmation testing and that you disclose the medication to whoever is reviewing the result.
The Medical Review Officer’s Role
In regulated workplace testing, a positive confirmed result does not go straight to your employer. It first reaches a Medical Review Officer (MRO), a licensed physician whose job is to determine whether there is a legitimate medical explanation. If you have a prescription for a benzodiazepine or an opioid, for instance, the MRO can verify that with your prescribing doctor and report the result as negative.11PubMed Central. The role of physicians as medical review officers in workplace drug testing programs. In pursuit of the last nanogram The MRO step is required by federal workplace drug-testing regulations and adds a layer of protection against people losing their jobs over legitimate medication use. Clinical drug screens ordered in hospital or outpatient settings do not always go through an MRO, so the treating physician interprets the results directly.
Can Secondhand Smoke or Passive Exposure Cause a Positive Result
The “I was just in the same room” defense is one of the most common concerns around cannabis testing, and the research on it is more nuanced than people expect. Studies that placed non-smokers in an unventilated room with heavy cannabis smoke found that extreme exposure could produce urine concentrations above the 50 ng/mL immunoassay cutoff, but only rarely, and only in the hours immediately after exposure. At higher screening cutoffs (75 or 100 ng/mL), no non-smokers tested positive at all. Room ventilation substantially reduced exposure levels, meaning that real-world scenarios like a party with open windows are far less risky than an enclosed, smoke-filled lab chamber.12PubMed Central. Non-Smoker Exposure to Secondhand Cannabis Smoke. I. Urine Screening and Confirmation Results
In practical terms, a positive from passive cannabis exposure is possible but very unlikely under normal social circumstances. It essentially requires prolonged confinement in a small, unventilated space with active heavy smoking, which is the kind of situation anyone would obviously recognize. A casual walk through a park where someone is smoking nearby is not going to trigger a positive on a 3477 panel.
How Long Drugs Stay Detectable in Urine
Detection windows vary enormously by substance, by how much was used, and by individual metabolism. As a rough guide for a single or occasional dose:
- Amphetamines: one to three days
- Barbiturates: short-acting types clear in a few days; long-acting phenobarbital can persist for weeks
- Benzodiazepines: short-acting types like alprazolam clear within a few days, but long-acting ones like diazepam can be detectable for a week or more
- Cannabinoids: a few days for occasional use, but heavy daily users may test positive for a month or longer because THC metabolites accumulate in body fat
- Cocaine metabolite: two to four days
- Opiates: two to three days for morphine and codeine
- Oxycodone: two to four days
- PCP: up to a week for casual use, potentially longer with heavy use
- Methadone: roughly seven to ten days
Individual factors like hydration, body composition, kidney function, liver metabolism, and even genetic variation in drug-metabolizing enzymes can shift these windows in either direction.13Anaesthesia & Intensive Care Medicine. Modes of drug elimination and bioactive metabolites Someone with a faster metabolism and lower body fat will clear most substances more quickly than someone with the opposite profile. There is no reliable way to “flush” your system faster; drinking excessive water mainly risks producing a dilute specimen, which, as discussed above, creates its own set of problems.
When Oral Fluid or Hair Testing Is Used Instead
Urine remains the most common specimen for drug testing in both clinical and workplace settings, but it is not the only option. Oral fluid (saliva) testing has gained ground because collection is directly observed and harder to tamper with. A comparison of urine and oral fluid testing found that the two matrices performed similarly on average across ten drug classes when analyzed by LC-MS/MS, though certain drugs showed differences: cocaine and methadone were more frequently detected in urine, while buprenorphine and tramadol showed up more often in oral fluid. Heroin was also more frequently detected in saliva.14PubMed Central. Comparing presumptive with direct-to-definitive drug testing in oral fluid vs. urine for a U.S. national sample of individuals misusing drugs
Hair testing covers a much longer detection window, generally around 90 days, and is sometimes used for pre-employment screening or legal proceedings where a longer history is relevant. However, hair testing has its own blind spots. A study comparing hair and urine testing in young adult opioid users found that urine was better at confirming self-reported use of marijuana, benzodiazepines, and heroin, while hair was better at detecting cocaine and oxycodone use. Hair testing also uncovered more unreported cocaine and oxycodone use, suggesting it catches some use that urine misses, and vice versa.15PubMed Central. A comparison of the utility of urine- and hair testing in detecting self-reported drug use among young adult opioid users Neither matrix is perfect, and the choice between them usually comes down to the purpose of the test and the detection window that matters most.
Newer Substances the Standard Panel Can Miss
The 3477 panel was designed around the drug classes that dominated clinical and workplace concerns for decades. Newer synthetic substances can slip through. Synthetic cannabinoids (sometimes called “K2” or “Spice”) will not trigger the THC immunoassay because they are chemically distinct from delta-9-THC, even though they hit the same brain receptors. Fentanyl, which has driven the opioid overdose crisis, is not reliably detected by standard opiate immunoassays; labs that want to catch fentanyl need a dedicated assay or must rely on confirmatory mass spectrometry. Similarly, novel stimulants like synthetic cathinones (“bath salts”) will not trigger a standard amphetamine screen in most cases.
If you are a clinician ordering the test or a patient wondering what it covers, it is worth knowing that a negative comprehensive screen does not rule out all possible substance use. Labs offer add-on panels for fentanyl, synthetic cannabinoids, and designer stimulants, but those have to be specifically ordered. The 3477 panel catches the well-established drug classes reliably, but the landscape of misused substances evolves faster than standard panel codes.
Why the Same Panel Code Can Look Different at Different Labs
A source of confusion is that “3477” is a proprietary order code, not a universally standardized panel. Quest Diagnostics uses it for their version of a comprehensive urine drug screen, but another reference lab might use a completely different code number for an equivalent panel. Even within the same lab, the panel composition can differ based on the ordering context. A hospital emergency department might order a 3477 panel that includes tricyclic antidepressants for overdose evaluation, while an employer ordering the same code through an occupational health account might get a version without them. The underlying technology and the specimen validity checks are the same, but the specific analyte list is configurable.
If you are trying to figure out exactly what your test will cover, the most reliable source is the lab’s published test menu, which you can usually find online by searching the test code and the lab’s name. The requisition form your provider fills out will also specify each drug class included. Asking “what’s on the panel?” before you provide the specimen is completely reasonable and not suspicious; medical professionals expect the question.